SSRI treatment during pregnancy: are we asking the right questions?
Wisner
Katherine L
KL
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pennsylvania 15213, USA. WisnerKL@upmc.edu
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D009357:Neonatal Abstinence Syndrome / Q000453:epidemiology / Q000209:etiology; D016017:Odds Ratio; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States
D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors